Institutional Fund
Superstring Capital Management LP
New York, NYCIK 19311185 filings on record
Portfolio Value
$139.97M
Q1 2026
Holdings
35
Reported positions
New Buys
15
Opened this quarter
QoQ Change
-25.1%
from $186.78M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Summit Therapeutics Inc12.1%
- Immunovant Inc6.3%
- Cogent Biosciences Inc6.2%
- Savara Inc6.2%
- Urogen Pharma Ltd5.0%
- Definium Therapeutics Inc4.7%
- Other59.5%
Portfolio Holdings
35 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Summit Therapeutics Inc | 892.9K | $16.93M | 12.1% | +892.9K | New |
| 2 | Immunovant Inc | 357.6K | $8.88M | 6.3% | +68.9K | Added |
| 3 | Cogent Biosciences Inc | 225.2K | $8.67M | 6.2% | −141.1K | Reduced |
| 4 | Savara Inc | 1.59M | $8.66M | 6.2% | +590.6K | Added |
| 5 | Urogen Pharma Ltd | 387.4K | $6.96M | 5.0% | −331.0K | Reduced |
| 6 | Definium Therapeutics Inc | 351.5K | $6.64M | 4.7% | +351.5K | New |
| 7 | Vir Biotechnology Inc | 730.5K | $6.55M | 4.7% | +730.5K | New |
| 8 | Vaxcyte Inc | 110.5K | $6.42M | 4.6% | +110.5K | New |
| 9 | Celldex Therapeutics Inc New | 180.0K | $5.71M | 4.1% | +91.7K | Added |
| 10 | Sionna Therapeutics Inc | 141.0K | $5.65M | 4.0% | −39.6K | Reduced |
25 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio